v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 48,803 $ 46,064
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for credit losses 1,000 1,700
Depreciation and amortization 1,539 1,530
Net accretion of securities premiums and discounts (2,095) (560)
Stock based compensation expense 6,609 5,192
Increase in cash surrender value of BOLI (1,300) (1,230)
Net gain on sale of OREO (340) 0
Decrease in deferred income taxes, net 10,990 1,125
Realized gain on sale of securities available-for-sale (45) 0
Net changes in:    
Other assets 8,075 2,943
Other liabilities 489 4,246
Net cash provided by operating activities 73,725 61,010
Cash flows from investing activities:    
Net (increase)/decrease in loans and leases held for investment (60,815) 54,064
Purchase of available-for-sale securities (78,311) (123,285)
Purchase of held-to-maturity securities (2,435) (6,351)
Proceeds from sales, maturities, calls and pay downs of available-for-sale securities 87,420 24,099
Proceeds from maturities, calls and pay downs of held-to-maturity securities 24,821 26,867
Purchase of premises and equipment (13,036) (3,266)
Purchase of other investments (4,723) (3,441)
Proceeds from sale of OREO 5,840 0
Proceeds from sale of assets 0 60
Net cash used in investing activities (41,239) (31,253)
Cash flows from financing activities:    
Net increase in deposits 115,137 61,225
Cash dividends paid (7,264) (6,481)
Restricted stock vesting distribution (6,303) 0
Cash used in share repurchase program 0 (2,934)
Purchase of treasury stock (279) (2,378)
Net cash provided by financing activities 101,291 49,432
Net change in cash and cash equivalents 133,777 79,189
Cash and cash equivalents, beginning of period 144,864 212,563
Cash and cash equivalents, end of period 278,641 291,752
Supplemental disclosures of cash flow information:    
Cash paid for interest 30,853 32,930
Income taxes paid 8 10,002
Supplemental disclosures of non-cash transactions:    
Accrued cash dividend on restricted stock (107) (287)
Net (increase)/decrease in unrealized losses on available-for-sale securities $ (11,314) $ 8,935